Showcases Stock ranks Forex

Sonnet Biotherapeutics Holdings Inc (SONN)
0.288  -0.013 (-4.38%) 08-08 15:59
Open: 0.2931 Pre. Close: 0.3012
High: 0.302 Low: 0.2812
Volume: 412,914 Market Cap: 17M
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 0.3 - 0.302 0.302 - 0.303
Low: 0.277 - 0.278 0.278 - 0.279
Close: 0.288 - 0.29 0.29 - 0.292
Stock Technical Analysis
Target: Six months: 0.35
One year: 0.37
Support: Support1: 0.26
Support2: 0.22
Resistance: Resistance1: 0.30
Resistance2: 0.32
Pivot: 0.29
Moving Averages: MA(5): 0.29
MA(20): 0.29
MA(100): 0.30
MA(250): 0.42
MACD: MACD(12,26):
%K %D: %K(14,3): 54.44
%D(3): 51.48
RSI: RSI(14): 51.92
52-Week: High: 2.07
Low: 0.23
Change(%): -67.3
Average Vol(K): 3-Month: 1306
10-Days: 431
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

[ SONN ] has closed below upper band by 48.7%. Bollinger Bands are 40.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Mon, 25 Jul 2022
Comparing Petros Pharmaceuticals (NASDAQ:PTPI) and Sonnet BioTherapeutics (NASDAQ:SONN) - Defense World

Thu, 21 Jul 2022
Sonnet BioTherapeutics Announces Clinical Trial of SON-1010 in Healthy Volunteers - Digital Journal

Fri, 15 Jul 2022
Top Penny Stocks to Buy Now? 3 to Watch in July -

Thu, 09 Jun 2022
Sonnet BioTherapeutics (SONN) Stock Price: Why It Increased Over 19% Today - Pulse 2.0

Thu, 02 Jun 2022
Sonnet BioTherapeutics Announces Adjournment of Annual Meeting Due to Lack of Quorum - Yahoo Finance

Tue, 10 May 2022
Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update - Yahoo Finance

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M) 60.59
% Held by Insiders 58790000.00
% Held by Institutions 3.14
Shares Short (K) 2130
Shares Short Prior Month (K)
Stock Financials
EPS -27600000.000
Book Value (p.s.)
Profit Margin
Operating Margin -3.00
Return on Assets (ttm) 895.8
Return on Equity (ttm) -152.2
Qtrly Rev. Growth 708750.0
Gross Profit (p.s.)
Sales Per Share -4338.417
EBITDA (p.s.) -131083336.000
Qtrly Earnings Growth -0.60
Operating Cash Flow (M)
Levered Free Cash Flow (M) -25.48
Stock Valuation
PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow 0.25
Stock Dividends
Dividend Yield
Dividend Growth 266640.000

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android